CN104099424A - Method for preparing length relying probe for detecting gene mutation - Google Patents
Method for preparing length relying probe for detecting gene mutation Download PDFInfo
- Publication number
- CN104099424A CN104099424A CN201410363255.4A CN201410363255A CN104099424A CN 104099424 A CN104099424 A CN 104099424A CN 201410363255 A CN201410363255 A CN 201410363255A CN 104099424 A CN104099424 A CN 104099424A
- Authority
- CN
- China
- Prior art keywords
- probe
- sequence
- preparation
- length
- gsf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a method for preparing a length relying probe for detecting gene mutation. The method comprises the following steps: 1) selecting a carrier irrelevant to a target sequence to be detected as a template, and designing an amplimer sequence of a length relying probe pair according to a target nucleotide sequence and an unrelated sequence; 2) manually synthesizing a primer; 3) conducting PCR amplification; 4) purifying and recycling a PCR product; 5) digesting the PCR product by adopting a T7 excision enzyme; 6) recycling ssDNA. The method for preparing the MLPA probe is low in cost, all operations of amplification, enzyme digestion and the like can be finished only through a PCR instrument, dsDNA and nucleotide which are not digested completely are digested and excluded by utilization of the T7 excision enzyme, the probe preparation efficiency is improved, and the hybridization efficiency in the MLPA experiment is improved.
Description
Technical field
The present invention relates to oligonucleotide probe preparation, be specially and can be used for detecting transgenation, comprise that the length of single nucleotide polymorphism (SNP), copy number variation (CNV) and numerical abnormalities of chromosomes relies on the preparation method of probe.
Background technology
Detect transgenation and be the important auxiliary diagnosis means of the Main Means of diagnosis genetic diseases and other metabolism, neural class disease.Transgenation comprises as single nucleotide polymorphism (SNPs), copy number variation (CNVs), gene fragment repetition and disappearance (Ins/Del), numerical abnormalities of chromosomes, gene methylation etc.Wherein single nucleotide polymorphism (SNPs), copy number variation (CNVs) and numerical abnormalities of chromosomes are the main Types detecting at present in gene mutation type.
The technique means that detects at present transgenation be take round pcr and PCR and is prolonged raw technology as main, and round pcr has that sense cycle is short, detection sensitivity is high, detected result accuracy rate is high, detected result is reliable.Yet; round pcr can only be realized a reaction tubes and analyze a gene locus; efficiency is low; while round pcr having relatively high expectations to sample DNA quality; for lower concentration inferior quality sample DNA, often there will be false negative or false-positive result,, site part methyl high for some special sample DNA(CG content) the round pcr ability mailbox that also often seems.Current will to as numerous different heredity, nerve, cardiovascular, cerebrovascular disease carry out the detection of molecular biology specialty, early stage sample sorting loaded down with trivial details, testing amount is large.Therefore, detection in Gene Mutation is badly in need of a kind of high-throughput, detection method fast and easily.
The technology of common high throughput testing transgenation has gene chip, multiple-pass capillary tube electrophoresis, dhplc analysis, the order-checking of two generations etc.Although these methods can realize the detection of " the corresponding entry of monocyte sample ", yet the detectivity to " Multi-example corresponding entry " mode is limited, its limitation mainly to detect sample DNA require correctness high, detected result to depend on to detect the degree of depth, cost is high.For disposable acquisition multiple goal DNA product fragment, adopt comparatively cheap multiple PCR technique, but target dna causes phase mutual interference and primer-oligomerization body between primer sequence to make this technology for detection number gene receive very large restriction more, generally can be over 10.
The Dr. Schouten JP of Holland in 2002 has created a kind of new detection in Gene Mutation technology and has detected for medical science, this technology is multiple join dependency probe amplification technology (Multiplex Ligation dependent Primers Amplification, MLPA) its principle is to rely on probe to (Fig. 1) for different target gene site design lengths, this length relies on one end tool gene specific of probe to two sequences, they with after the renaturation of target gene region, only stay a breach separately, in this simultaneously all length rely on one end that probe centering do not hybridize with goal gene and be all connected to identical base sequence (both universal primer sequence, GS) for PCR, when being connected with target area renaturation and under the effect of ligase enzyme, length dependence probe pair itself becomes like this template DNA of PCR, and increase and reach the effect that signal amplifies by a pair of universal primer, because the probe of the target gene site design for different is different to length, (need not be by order-checking means by separated PCR product size, by agarose gel electrophoresis or capillary electrophoresis, can reach separated effect) just can know whether the existence of target gene, can carry out qualitative analysis to target gene, also can carry out relative quantitative assay.
MLPA technology has (not needing expensive and complicated operating equipment) easy and simple to handle, specificity high (specific recognition of probe renaturation and ligase enzyme) and high-throughput (single tube can be surveyed nearly 45 gene locuss), need DNA sample amount low (only needing 20ng/ μ l DNA), Application Areas extensively (can be applicable to single nucleotide polymorphism (SNP), copy number variation (CNV), gene fragment disappearance and repetition (Int/Del), numerical abnormalities of chromosomes, the analysis of methylation analysis and mRNA) feature.Over the years, surpass in the research report that has up to a hundred pieces and applied this technology.
The length relating in MLPA technology for target gene relies on probe pair, wherein the right design of length dependence probe is difficult point, Holland scientist has creatively utilized the characteristic of M13 single stranded phage, at the derivative sequence two ends of insertion, designed restriction enzyme (RE) recognition site dexterously, to adopt double digestion to obtain length, rely on probe pair, overcome current oligonucleotide chemosynthesis and be generally difficult to reach difficulty more than 50mer.
Its principle is exactly by the irrelevant sequence varying in size of each M13 carrier or irrelevant template (Unrelated Template, UT) thereby introducing single-stranded probe obtains the different single-stranded probe of length.This single-stranded probe biological method is very loaded down with trivial details, not only needs the processes such as gene clone, virus transfection, plasmid extraction, also must buy the M13 carrier of a set of costliness, and in addition, operation M13 virus is very easily polluted.Simultaneously in order to monopolize MLPA application market, the dutch company MRC-Holland M13 carrier of not resaled now, therefore, it is anxious to be resolved that length relies on the right preparation method of probe.
Summary of the invention
The object of the invention is to rely on the probe problem loaded down with trivial details to biological preparation method for above-mentioned MLPA length, provide a kind of working method easy, pollute the MLPA length controlled, preparation efficiency is high and rely on the right preparation method of probe.
Another object of the present invention be to provide length that a kind of MLPA for for cardiovascular disorder relevant risk gene detects rely on probe to and the MLPA detection method of risk of cardiovascular diseases gene.
To achieve these goals, the present invention has adopted following technical scheme (Fig. 2):
1. for target site to be measured or two pairs of primers of fragment design, a pair of is universal primer, for follow-up pcr amplification, detects, and is respectively GSF and GSR, and this is irrelevant to the native sequences (NS) in primer sequence and target site to be measured or fragment and long probe; Detection primer for target site to be measured or fragment, is respectively TSF and TSR.
2. preparation length relies on the long probe of probe centering:
1) long probe of length dependence probe centering is comprised of three parts, is respectively GSR, NS and TSR;
2) 5 ' of GSR end is modified with reporter group;
3) determine one section with target site to be measured or fragment and the irrelevant native sequences (NS) of universal primer;
4) for the design pair for amplification primer of long probe, be respectively GSR-N ' and TSR-N ', wherein GSR-N ' is comprised of the sequence of the sequence of GSR and the 18bp left and right of NS sequence 3 ' end, TSR-N ' is comprised of the sequence of the reverse complementary sequence of object long probe 5 ' terminal sequence and the 18bp left and right reverse complemental of NS sequence 5 ' end, and the 5 ' end of TSR-N ' will be with phosphorylation modification;
5) with GSR-N ' and TSR-N ', take the nucleotide sequence of described long probe and carry out pcr amplification as template, obtain the Double-stranded nucleotide sequence of complementary strand 5 ' end phosphorylation modification;
6) purifying reclaims PCR product, removes the underproof PCR product of primer dimer and amplification length;
7) dsDNA of the PCR product after adopting nucleic acid T7 exonuclease to above purifying digests, and removes that ssDNA of 5 ' end phosphorylation mark;
8) adopt ssDNA purifying to reclaim test kit digestion after product is reclaimed, obtain the long probe that length relies on probe centering.
9), according to the needs of test set, 3 ' end of long probe is carried out to the modification of reporter group.
10) by ultraviolet spectrophotometer, the long probe OD260 obtaining and the ratio of OD280 are being detected, its ratio is between 1.6 ~ 2.0, and packing is standby.If ratio, not within the scope of this, carries out purifying to the long probe obtaining again.
3. preparation length relies on the short probe of probe centering
1) the short probe of length dependence probe centering is comprised of two parts, is respectively GSF and TSF;
2) for short probe, relate to pair for amplification primer, be respectively GSF-N ' and TSF-N ', wherein GSF-N ' is comprised of the sequence of the 15bp left and right of the sequence 5 ' end of GSF, the sequence of the 15bp left and right reverse complemental of TSF-N ' in the reverse complementary sequence of TSF sequence 3 ' end forms, and will be with upper phosphorylation modification at the 5 ' end of its GSF-N ';
3) with GSF-N ' and TSF-N ', take the nucleotide sequence of described short probe and carry out pcr amplification as template, obtain the Double-stranded nucleotide sequence of complementary strand 5 ' end phosphorylation modification;
4) purifying reclaims PCR product, removes primer dimer and underproof PCR product;
5) dsDNA of the PCR product after adopting nucleic acid T7 exonuclease to above purifying digests, and removes that ssDNA of 5 ' end phosphorylation mark;
6) adopt ssDNA purifying to reclaim test kit digestion after product is reclaimed, obtain the short probe that length relies on probe centering.
7) by ultraviolet spectrophotometer, the short probe OD260 obtaining and the ratio of OD280 are being detected, its ratio is between 1.6 ~ 2.0, and packing is standby.If ratio, not within the scope of this, carries out purifying to the short probe obtaining again.
The dsDNA sequence of 5 ' the end phosphorylation modification that described pcr amplification obtains need first be carried out T7 exonuclease through purifying again.
3 ' of described long probe holds reporter group in the modification of carrying out reporter group to select, according to detection means, determine and use which kind of reporter group, reporter group can be fluorophor, can select the albumen of particular dye sensitivity, also can select specific antibodies albumen.
In described T7 exonuclease digestion process, 1 T7 of unit exonuclease digestion for 1ug dsDNA.
MLPA probe preparation method of the present invention with adopt M13 phage to prepare MLPA to compare, have the following advantages:
1) pcr amplification primer is simple, only needs to consider the problem routinely of the PCR design of primers such as primer Tm value and length, by combining target nucleotide sequence, for masterplate design pair of primers.
2) utilize simple round pcr and T7 exonuclease digestion can obtain length and rely on probe pair, without phage, cultivate, can in one day, complete probe preparation work, greatly reduce MLPA technical threshold.
3) without cloning preparation, without specificity endonuclease digestion, simple to operate.
4) the required padding sequence of probe source is various and convenient, can make different probe padding sequence be consistent, and also can select as required the different masterplates required padding sequence that increases, and the non-specific hybridization while reducing hybridization, improves and be detected as power.
Accompanying drawing explanation
The Hybridization principle schematic diagram of Fig. 1 MLPA technology;
Fig. 2 probe preparation flow of the present invention figure;
Agarose gel electrophoresis analytical results figure in Fig. 3 embodiment of the present invention 1;
Electrocapillary phoresis analytical results figure in Fig. 4 embodiment of the present invention 2.
Embodiment
With specific examples, preparation method of the present invention is described by reference to the accompanying drawings, but not as a limitation of the invention, be specially the preparation and the detection thereof that with multiplex ligation amplification technology, detect the length dependence probe of Mammals cardiovascular disorder genes involved.
The length that embodiment 1 detects Mammals cardiovascular disorder genes involved ACE gene relies on right preparation and the detection thereof of probe, comprises the following steps:
1. for two pairs of primers of ACE gene design to be measured, a pair of is universal primer, for follow-up pcr amplification, detects, and is respectively GSF and GSR, and this is irrelevant to the native sequences (NS) in primer sequence and target site to be measured or fragment and long probe; Detection primer for target site to be measured or fragment, is respectively TSF and TSR.
2. preparation length relies on the long probe of probe centering:
1) determine one section with ACE gene to be measured and the irrelevant native sequences (NS) of universal primer, in NS and ACE gene order hen house to be measured;
2) for long probe, relate to pair for amplification primer, be respectively GSR-N ' and TSR-N ', wherein GSR-N ' is comprised of the sequence of the sequence of GSR and the 18bp left and right of NS sequence 3 ' end, TSR-N ' is comprised of the sequence of the reverse complementary sequence of object long probe 5 ' terminal sequence and the 18bp left and right reverse complemental of NS sequence 5 ' end, and the 5 ' end of TSR-N ' will be with phosphorylation modification;
3) pcr amplification, obtains the Double-stranded nucleotide sequence that complementary strand 5 ' is held phosphorylation modification;
4) purifying reclaims PCR product, removes primer dimer and underproof PCR product;
5) Double-stranded nucleotide sequence of the PCR product after adopting T7 exonuclease to above purifying digests, and removes that ssDNA of 5 ' end phosphorylation mark;
6) adopt ssDNA purifying to reclaim test kit digestion after product is reclaimed, obtain the long probe that length relies on probe centering;
7) 3 ' end of long probe is carried out to the modification of reporter group;
8) long probe obtaining is being determined the quality of synthetic long probe by ultraviolet spectrophotometer.
3. preparation length relies on the short probe of probe centering
1) the short probe of length dependence probe centering is comprised of two parts, is respectively GSF and TSF;
2) for short probe, relate to pair for amplification primer, be respectively GSF-N ' and TSF-N ', wherein GSF-N ' is comprised of the sequence of the 18bp left and right of the sequence 5 ' end of GSF, the sequence of the 18bp left and right reverse complemental of TSF-N ' in the reverse complementary sequence of TSF sequence 3 ' end forms, and its 5 ' end will be with phosphorylation modification;
3) with GSF-N ' and TSF-N ', take the nucleotide sequence of described long probe and carry out pcr amplification as template, obtain the Double-stranded nucleotide sequence of complementary strand 5 ' end phosphorylation modification;
4) purifying reclaims PCR product, removes primer dimer and underproof PCR product;
5) Double-stranded nucleotide sequence of the PCR product after adopting T7 exonuclease to above purifying digests, and removes that ssDNA of 5 ' end phosphorylation mark;
6) adopt ssDNA purifying to reclaim test kit digestion after product is reclaimed, obtain the short probe that length relies on probe centering.
7) the short probe obtaining is being determined the quality of synthetic short probe by ultraviolet spectrophotometer.
4. by the length of ACE gene obtained above, rely on what is said or talked about for carrying out hybridization with Mammals nuclear DNA, connect laggard performing PCR amplification, PCR product is carried out to gel electrophoresis analysis.
The design of implementation step 1 long probe amplimer is synthetic.
Design the irrelevant amplimer that is easy to carry out pcr amplification of target fragment a pair of and to be measured and long probe nucleotide sequence, be respectively GSR-N ' and TSR-N ', the 5 ' end of TSR-N ' carries out phosphorylation modification, for the pcr amplification detection of long probe.
Select plasmid pET-28a(purchased from Novagen company) in a part of sequence be the template sequence (NS) irrelevant with target fragment to be detected, and prepare special-purpose universal primer GSR-N ' (the 18bp reverse complementary sequence by 5 ' end of GSR and NS sequence forms) and prepare the downstream primer TSR-N ' (reverse complementary sequence of the 23bp being held by TSR and NS sequence 3 ' forms) that ACE gene length probe is used according to the long probe sequence of ACE gene and NS sequences Design synthetic long probe.
The concrete nucleotides sequence of above-mentioned primer is classified as:
GSR:5'- CACACAGGAAACAGCTATGAC -3' 21bp
TSR:5'-ACCTGCTGCCTATACAGTCACTTTT-3' 25bp
GSR-N ': 5'-
gCGGTCCCAAAGGGTCAGTtCTAGAGCTAGGAGATGC-3'47 bp(underscore is partly the reverse complementary sequence of GSR, and remainder is the reverse complementary sequence of the 18bp of NS sequence 5 ' end)
TSR-N ': 5'-
tGGACGACGGATATGTCAGTGAAAAgACGAAGGATTACGTCCTCAGCG-3'48bp 5' end phosphorylation modification (underscore is partly the reverse complementary sequence of TSR sequence, and remainder is the reverse complementary sequence of the 23bp of NS sequence 3 ' end)
The concrete sequence of long probe fragment that final pcr amplification obtains is:
CACACAGGAAACAGCTATGAC(GSR sequence)
AGATCTCGAT CCTCTACGCC GGACGCATCG TGGCCGGCAT CACCGGCGCC ACAGGTGCGG TTGCTGGCGC CTATATCGCC GACATCACCG ATGGGGAAGA
TCGGGCTCGC CACTTCGGGC TCATGAGCGC TTGTTTCGGC GTGGGTATGG TGGCAGGCCC CGTGGCCGGG GGACTGTTGG GCGCCATCTC CTTGCATGCA
CCATTCCTTG CGGCGGCGGT GCTCAACGGC CTCAACCTAC TACTGGGCTG CTTCCTAATG CAGGAGTCGC(NS sequence)
ACCTGCTGCCTATACAGTCACTTTT(TSR sequence)
The pcr amplification of implementation step 2 long probes and the purifying of product thereof reclaim
Take plasmid pET-28a as template, use primer GSR-N ' and TSR-N ' to carry out PCR amplification.
1) PCR reaction system:
2) PCR response procedures
① 94℃ 3min
② 46℃ 30s
③ 72℃ 40s
④ go to ②,35 cycle
⑤ 72℃ 5min
3) purifying of PCR product reclaims
Use the DNA fragmentation purification kit of the CODE:51106 of Qiagen company to reclaim PCR product.
The design of the short probe amplification primer of implementation step 3 is synthetic.
Design the irrelevant amplimer that is easy to carry out pcr amplification of target fragment a pair of and to be measured, be respectively GSF-N ' and TSF-N ', the 5 ' end of TSF-N ' carries out phosphorylation modification, for the pcr amplification detection of short probe.
The concrete nucleotides sequence of above-mentioned primer is classified as:
GSF:5'- CGCCAGGGTTTCCCAGTCACGAC -3' 23bp
TSF:5'- TTTTATGTGGTTTCGCCAATTTTAT -3' 25 bp
GSF-N ': 5 ' the end 15bp reverse complementary sequence that 5'-GCGGTCCCAAAGGGT-3'15bp(is GSF)
TSF-N ': 5'-AAAATACACCAAAGC-3'15 bp(is 3 ' end 15bp reverse complementary sequence of TSR sequence)
The concrete sequence of short probe fragment that final pcr amplification obtains is:
TTTTATGTGGTTTCGCCAATTTTAT(TSF sequence)
CGCCAGGGTTTCCCAGTCACGAC(GSF sequence)
The pcr amplification of implementation step 4 short probes and the purifying of product thereof reclaim
The plasmid mammalian genes group DNA of take is template, uses primer GSR-N ' and TSR-N ' to carry out PCR amplification.
1) PCR reaction system:
2) PCR response procedures
① 94℃ 3min
② 46℃ 30s
③ 72℃ 40s
④ go to ②,35 cycle
⑤ 72℃ 5min
3) purifying of PCR product reclaims
Use the DNA fragmentation purification kit of the CODE:51106 of Qiagen company to reclaim PCR product.
The PCR product that implementation step 5 T7 exonuclease digestion purifying reclaim.
Use the T7 exonuclease of NEB company to digest PCR product, the digestion of PCR product is obtained to ssDNA probe.
Implementation step 6 ssDNA probe purifying reclaim and quality inspection.
Use the ssDNA purifying recovery test kit of the CODE:51106 of Qiagen company to carry out purifying recovery to the product of above-mentioned Lamda exonuclease digestion.
The probe obtaining is measured to the ratio of OD260 and OD280 by ultraviolet spectrophotometer, ratio is qualified between 1.6 ~ 2.0, and ratio is the PCR product within the scope of this not, need to carry out PCR product purification again.
Implementation step 7 MLPA experimental verifications.
1) hybridization
By the length of ACE gene obtained above, rely on probe to carrying out hybridization with mammalian genes group DNA.
Reaction system:
Hybridization buffer: 1.5ul
Probe is to (long probe and short probe equal proportion are mixed): 2.5ul (30fmol)
Genomic dna: more than 5ul(total amount 50ng)
Reaction conditions:
1. 95 ℃ of sex change 5min of genomic dna
2. then add 95 ℃ of 1min of hybridization buffer and probe
3. hybridize 60 ℃ 16 hours
2) connect
Linked system:
Hybridization product: 8ul
Taq ligase enzyme: 5U
10×Taq buffer :3ul
ddH
2O:up to 30ul
Condition of contact:
15min95 ℃ of reaction 7min of 54 ℃ of reactions.
① 54℃ 15min
② 95℃ 7min
3) PCR augmentation detection
PCR system:
PCR response procedures:
① 95℃ 5min
② 95℃ 30s
③ 60℃ 30s
④ 72℃ 40s
⑤ go to ②,40 cycle
⑥ 72℃ 5min
4) agarose gel electrophoresis analysis
Fig. 3 is shown in by analytical results schematic diagram, the MLPA result of ACE gene there will be three kinds of situations (ins 644bp, ins/del 644bp, 364, del 364 bp), the negative control that the water of take is masterplate does not have pcr amplification product, and probe prepared by provable the present invention can be used for MLPA experiment.
The length that embodiment 2 detects Mammals cardiovascular disorder genes involved ACE, GNB3, NOS3 gene relies on preparation and the detection thereof of probe groups, comprises the following steps:
1. the length dependence probe groups for ACE, GNB3, NOS3 gene designs a pair of universal primer, for follow-up pcr amplification, detect, be respectively GSF and GSR, this is irrelevant to the native sequences (NS) in primer sequence and target site to be measured or fragment and long probe.
The concrete nucleotides sequence of above-mentioned primer is classified as:
GSR:5'- CACACAGGAAACAGCTATGAC -3' 21bp
TSR:5'-ACCTGCTGCCTATACAGTCACTTTT-3' 25bp
2. for a pair of detection primer for target site to be measured or fragment of ACE gene design to be measured, be respectively TSF and TSR.
3. for a pair of detection primer for target site to be measured or fragment of GNB3 gene design to be measured, be respectively TSF1, TSRC1 and TSRT1.
4. for a pair of detection primer for target site to be measured or fragment of NOS3 gene design to be measured, be respectively TSF1, TSRG2 and TSRT2.
The design of implementation step 1 long probe amplimer is synthetic.
1. the length of preparation ACE gene relies on the long probe of probe centering:
Operation is with embodiment 1.
Concrete nucleotides sequence for the long probe amplimer of ACE gene is classified as:
GSR-N ': 5'-
gCGGTCCCAAAGGGTCAGTtCTAGAGCTAGGAGATGC-3'47 bp(underscore is partly the reverse complementary sequence of GSR, and remainder is the reverse complementary sequence of the 18bp of NS sequence 5 ' end)
TSR-N ': 5'-
tGGACGACGGATATGTCAGTGAAAAgACGAAGGATTACGTCCTCAGCG-3'48bp 5' end phosphorylation modification (underscore is partly the reverse complementary sequence of TSR sequence, and remainder is the reverse complementary sequence of the 23bp of NS sequence 3 ' end)
The concrete sequence of long probe fragment that final pcr amplification obtains is:
CACACAGGAAACAGCTATGAC(GSR sequence)
AGATCTCGAT CCTCTACGCC GGACGCATCG TGGCCGGCAT CACCGGCGCC ACAGGTGCGG TTGCTGGCGC CTATATCGCC GACATCACCG ATGGGGAAGA
TCGGGCTCGC CACTTCGGGC TCATGAGCGC TTGTTTCGGC GTGGGTATGG TGGCAGGCCC CGTGGCCGGG GGACTGTTGG GCGCCATCTC CTTGCATGCA
CCATTCCTTG CGGCGGCGGT GCTCAACGGC CTCAACCTAC TACTGGGCTG CTTCCTAATG CAGGAGTCGC(NS sequence)
ACCTGCTGCCTATACAGTCACTTTT(TSR sequence)
2. the length of preparation GNB3 gene relies on the long probe of probe centering:
Operation is with embodiment 1.
Concrete nucleotides sequence for the long probe amplimer of GNB3 gene is classified as:
GSR:5'- CACACAGGAAACAGCTATGAC -3' 21bp
TSRC1:5'- TCATCTGCGGCATCACGTCCGTGGC-3' 25bp
TSRT1:5'- TCATCTGCGGCATCACGTCTGTGGC-3' 25bp
GSR-N ': 5'-
gCGGTCCCAAAGGGTCAGTtCTAGAGCTAGGAGATGC-3'47 bp(underscore is partly the reverse complementary sequence of GSR, and remainder is the reverse complementary sequence of the 18bp of NS sequence 5 ' end)
TSRC1-N ': 5'-
aGTAGACGCCGTAGTGCAGGCACCGgACGAAGGATTACGTCCTCAGCG-3'48bp 5' end phosphorylation modification (underscore is partly the reverse complementary sequence of TSRC1 sequence, and remainder is the reverse complementary sequence of the 23bp of NS sequence 3 ' end)
TSRT1-N ': 5'-
aGTAGACGCCGTAGTGCAGACACCGgACGAAGGATTACGTCCTCAGCG-3'48bp 5' end phosphorylation modification (underscore is partly the reverse complementary sequence of TSRT1 sequence, and remainder is the reverse complementary sequence of the 23bp of NS sequence 3 ' end)
The concrete sequence of long probe fragment (GNB3 gene C site) that final pcr amplification obtains is:
CACACAGGAAACAGCTATGAC(GSR sequence)
AGATCTCGAT CCTCTACGCC GGACGCATCG TGGCCGGCAT CACCGGCGCC ACAGGTGCGG TTGCTGGCGC CTATATCGCC GACATCACCG ATGGGGAAGA
TCGCAAATTG TCGCGGCGAT TAAATCTCGC GCCGATCAAC TGGGTGCCAG CGTGGTGGTG TCGATGGTAG AACGAAGCGG CGTCGAAGCC TGTAAAGCGG
TCGGGCTCGC CACTTCGGGC TCATGAGCGC TTGTTTCGGC GTGGGTATGG TGGCAGGCCC CGTGGCCGGG GGACTGTTGG GCGCCATCTC CTTGCATGCA
CCATTCCTTG CGGCGGCGGT GCTCAACGGC CTCAACCTAC TACTGGGCTG CTTCCTAATG CAGGAGTCGC(NS1 sequence)
TCATCTGCGGCATCACGTCCGTGGC(TSRC1 sequence)
The concrete sequence of long probe fragment (GNB3 gene T site) that final pcr amplification obtains is:
CACACAGGAAACAGCTATGAC(GSR sequence)
AGATCTCGAT CCTCTACGCC GGACGCATCG TGGCCGGCAT CACCGGCGCC ACAGGTGCGG TTGCTGGCGC CTATATCGCC GACATCACCG ATGGGGAAGA
TCGCAAATTG TCGCGGCGAT TAAATCTCGC GCCGATCAAC TGGGTGCCAG CGTGGTGGTG TCGATGGTAG AACGAAGCGG CGTCGAAGCC TGTAAAGCGG
TCGGGCTCGC CACTTCGGGC TCATGAGCGC TTGTTTCGGC GTGGGTATGG TGGCAGGCCC CGTGGCCGGG GGACTGTTGG GCGCCATCTC CTTGCATGCA
CCATTCCTTG CGGCGGCGGT GCTCAACGGC CTCAACCTAC TACTGGGCTG CTTCCTAATG CAGGAGTCGC(NS1 sequence)
TCATCTGCGGCATCACGTCTGTGGC(TSRT1 sequence)
3. the length of preparation NOS3 gene relies on the long probe of probe centering:
Operation is with embodiment 1.
Concrete nucleotides sequence for the long probe amplimer of NOS3 gene is classified as:
GSR:5'- CACACAGGAAACAGCTATGAC -3' 21bp
TSRG2:5'- TGCTGCAGGCCCCAGATGAGCCCCC-3' 25bp
TSRT2:5'- TGCTGCAGGCCCCAGATGATCCCCC-3' 25bp
GSR-N ': 5'-
gCGGTCCCAAAGGGTCAGTtCTAGAGCTAGGAGATGC-3'47 bp(underscore is partly the reverse complementary sequence of GSR, and remainder is the reverse complementary sequence of the 18bp of NS sequence 5 ' end)
TSRG2-N ': 5'-
aCGACGTCCGGGGTCTACTCGGGGGgACGAAGGATTACGTCCTCAGCG-3'48bp 5' end phosphorylation modification (underscore is partly the reverse complementary sequence of TSRG2 sequence, and remainder is the reverse complementary sequence of the 23bp of NS sequence 3 ' end)
TSRT2-N ': 5'-
aCGACGTCCGGGGTCTACTAGGGGGgACGAAGGATTACGTCCTCAGCG-3'48bp 5' end phosphorylation modification (underscore is partly the reverse complementary sequence of TSRT2 sequence, and remainder is the reverse complementary sequence of the 23bp of NS sequence 3 ' end)
The concrete sequence of long probe fragment (NOS3 gene G site) that final pcr amplification obtains is:
CACACAGGAAACAGCTATGAC(GSR sequence)
AGATCTCGAT CCTCTACGCC GGACGCATCG TGGCCGGCAT CACCGGCGCC ACAGGTGCGG TTGCTGGCGC CTATATCGCC GACATCACCG ATGGGGAAGA
TCGCAAATTG TCGCGGCGAT TAAATCTCGC GCCGATCAAC TGGGTGCCAG CGTGGTGGTG TCGATGGTAG AACGAAGCGG CGTCGAAGCC TGTAAAGCGG
CCGCTGGATG ACCAGGATGC CATTGCTGTG GAAGCTGCCT GCACTAATGT TCCGGCGTTA TTTCTTGATG TCTCTGACCA GACACCCATC AACAGTATTA
TCGGGCTCGC CACTTCGGGC TCATGAGCGC TTGTTTCGGC GTGGGTATGG TGGCAGGCCC CGTGGCCGGG GGACTGTTGG GCGCCATCTC CTTGCATGCA
CCATTCCTTG CGGCGGCGGT GCTCAACGGC CTCAACCTAC TACTGGGCTG CTTCCTAATG CAGGAGTCGC(NS2 sequence)
TGCTGCAGGCCCCAGATGAGCCCCC(TSRG2 sequence)
The concrete sequence of long probe fragment (NOS3 gene T site) that final pcr amplification obtains is:
CACACAGGAAACAGCTATGAC(GSR sequence)
AGATCTCGAT CCTCTACGCC GGACGCATCG TGGCCGGCAT CACCGGCGCC ACAGGTGCGG TTGCTGGCGC CTATATCGCC GACATCACCG ATGGGGAAGA
TCGCAAATTG TCGCGGCGAT TAAATCTCGC GCCGATCAAC TGGGTGCCAG CGTGGTGGTG TCGATGGTAG AACGAAGCGG CGTCGAAGCC TGTAAAGCGG
CCGCTGGATG ACCAGGATGC CATTGCTGTG GAAGCTGCCT GCACTAATGT TCCGGCGTTA TTTCTTGATG TCTCTGACCA GACACCCATC AACAGTATTA
TCGGGCTCGC CACTTCGGGC TCATGAGCGC TTGTTTCGGC GTGGGTATGG TGGCAGGCCC CGTGGCCGGG GGACTGTTGG GCGCCATCTC CTTGCATGCA
CCATTCCTTG CGGCGGCGGT GCTCAACGGC CTCAACCTAC TACTGGGCTG CTTCCTAATG CAGGAGTCGC(NS2 sequence)
TGCTGCAGGCCCCAGATGATCCCCC(TSRT2 sequence)
The pcr amplification of implementation step 2 long probes and the purifying of product thereof reclaim
Operation, with embodiment 1, is used FAM fluorophor to modify at long probe 3 ' end.
The design of the short probe amplification primer of implementation step 3 is synthetic.
1. the length of preparation ACE gene relies on the short probe of probe centering:
Operation is with embodiment 1.
Concrete nucleotides sequence for the short probe amplification primer of ACE gene is classified as:
GSF:5'- CGCCAGGGTTTCCCAGTCACGAC -3' 23bp
TSF:5'- TTTTATGTGGTTTCGCCAATTTTAT -3' 25 bp
GSF-N ': 5 ' the end 15bp reverse complementary sequence that 5'-GCGGTCCCAAAGGGT-3'15bp(is GSF)
TSF-N ': 5'-AAAATACACCAAAGC-3'15 bp(is 3 ' end 15bp reverse complementary sequence of TSF sequence)
The concrete sequence of short probe fragment (ACE gene) that final pcr amplification obtains is:
TTTTATGTGGTTTCGCCAATTTTAT(TSF sequence)
CGCCAGGGTTTCCCAGTCACGAC(GSF sequence)
2. the length of preparation GNB3 gene relies on the short probe of probe centering:
Operation is with embodiment 1.
Concrete nucleotides sequence for the short probe amplification primer of GNB3 gene is classified as:
GSF:5'- CGCCAGGGTTTCCCAGTCACGAC -3' 23bp
TSF1:5'- CTTCTCCCTCAGTGGCCGCCTACTA -3' 25 bp
GSF-N ': 5 ' the end 15bp reverse complementary sequence that 5'-GCGGTCCCAAAGGGT-3'15bp(is GSF)
TSF1-N ': 5'-GAAGAGGGAGTCACC-3'15 bp(is 3 ' end 15bp reverse complementary sequence of TSF1 sequence)
The concrete sequence of short probe fragment (GNB3 gene) that final pcr amplification obtains is:
CTTCTCCCTCAGTGGCCGCCTACTA(TSF1 sequence)
CGCCAGGGTTTCCCAGTCACGAC(GSF sequence)
3. the length of preparation NOS3 gene relies on the short probe of probe centering:
Operation is with embodiment 1.
Concrete nucleotides sequence for the short probe amplification primer of NOS3 gene is classified as:
GSF:5'- CGCCAGGGTTTCCCAGTCACGAC -3' 23bp
TSF2:5'- AGAACTCTTCCTTCTGCCCCCCGAG -3' 25 bp
GSF-N ': 5 ' the end 15bp reverse complementary sequence that 5'-GCGGTCCCAAAGGGT-3'15bp(is GSF)
TSF2-N ': 5'-TCTTGAGAAGGAAGA-3'15 bp(is 3 ' end 15bp reverse complementary sequence of TSF2 sequence)
The concrete sequence of short probe fragment (NOS3 gene) that final pcr amplification obtains is:
AGAACTCTTCCTTCTGCCCCCCGAG(TSF2 sequence)
CGCCAGGGTTTCCCAGTCACGAC(GSF sequence)
The pcr amplification of implementation step 4 short probes and the purifying of product thereof reclaim
Operation is with embodiment 1.
The PCR product that implementation step 5 T7 exonuclease digestion purifying reclaim.
Operation is with embodiment 1.
Implementation step 6 ssDNA probe purifying reclaim and quality inspection.
Operation is with embodiment 1.
Implementation step 7 MLPA experimental verifications.
1) hybridization
By the length of ACE gene obtained above, rely on probe to carrying out hybridization with mammalian genes group DNA.
Reaction system:
Hybridization buffer: 1.5ul
Probe is to (long probe and short probe equal proportion are mixed): 2.5ul (30fmol)
Genomic dna: more than 5ul(total amount 50ng)
Reaction conditions:
1. 95 ℃ of sex change 5min of genomic dna
2. then add 95 ℃ of 1min of hybridization buffer and probe
3. hybridize 60 ℃ 16 hours
2) connect
Linked system:
Hybridization product: 8ul
Taq ligase enzyme: 5U
10×Taq buffer :3ul
ddH2O:up to 30ul
Condition of contact:
15min95 ℃ of reaction 7min of 54 ℃ of reactions.
① 54℃ 15min
② 95℃ 7min
3) PCR augmentation detection
PCR system:
PCR response procedures:
① 95℃ 5min
② 95℃ 30s
③ 60℃ 30s
④ 72℃ 40s
⑤ go to ②,40 cycle
⑥ 72℃ 5min
4) electrocapillary phoresis analysis
Analytical results is shown in Fig. 4, detects genomic MLPA result and can go out item, and the negative control that the water of take is masterplate does not have PCR amplified production, and probe prepared by provable the present invention can be used for MLPA experiment.
The upper marine excellent medical biotechnology of <110> company limited
<120> length for detection of transgenation relies on probe preparation method
<160> 23
<210> 1
<211> 21
<212> DNA
<213> artificial sequence
<220>
<223> GSR
<400> 1
cacacaggaa acagctatga c 21
<210> 2
<211> 25
<212> DNA
<213> artificial sequence
<220>
<223> TSR
<400> 2
acctgctgcc tatacagtca ctttt 25
<210> 3
<211> 37
<212> DNA
<213> artificial sequence
<220>
<223> GSR-N’
<400> 3
gcggtcccaa agggtcagtt ctagagctag gagatgc 37
<210> 4
<211> 47
<212> DNA
<213> artificial sequence
<220>
<223> TSR-N’
<400> 4
tggacgacgg atatgtcagtg aaaagacgaa ggattacgtc ctcagcg 47
<210> 5
<211> 23
<212> DNA
<213> artificial sequence
<220>
<223> GSF
<400> 5
cgccagggtt tcccagtcac gac 23
<210> 6
<211> 25
<212> DNA
<213> artificial sequence
<220>
<223> GSF
<400> 6
ttttatgtgg tttcgccaat tttat 25
<210> 7
<211> 15
<212> DNA
<213> artificial sequence
<220>
<223> GSF-N’
<400> 7
gcggtcccaa agggt 15
<210> 8
<211> 15
<212> DNA
<213> artificial sequence
<220>
<223> TSF-N’
<400> 8
aaaatacacc aaagc 15
<210> 9
<211> 25
<212> DNA
<213> artificial sequence
<220>
<223> TSRC1
<400> 9
tcatctgcgg catcacgtcc gtggc 25
<210> 10
<211> 25
<212> DNA
<213> artificial sequence
<220>
<223> TSRT1
<400> 10
tcatctgcgg catcacgtct gtggc 25
<210> 11
<211> 48
<212> DNA
<213> artificial sequence
<220>
<223> TSRC1-N’
<400> 11
agtagacgcc gtagtgcagg caccggacga aggattacgt cctcagcg 48
<210> 12
<211> 48
<212> DNA
<213> artificial sequence
<220>
<223> TSRT1-N’
<400> 12
agtagacgcc gtagtgcaga caccggacga aggattacgt cctcagcg 48
<210> 13
<211> 25
<212> DNA
<213> artificial sequence
<220>
<223> TSRG2
<400> 13
tgctgcaggc cccagatgag ccccc 25
<210> 14
<211> 25
<212> DNA
<213> artificial sequence
<220>
<223> TSRT2
<400> 14
tgctgcaggc cccagatgat ccccc 25
<210> 15
<211> 48
<212> DNA
<213> artificial sequence
<220>
<223> TSRG2-N’
<400> 15
acgacgtccg gggtctactc ggggggacga aggattacgt cctcagcg 48
<210> 16
<211> 48
<212> DNA
<213> artificial sequence
<220>
<223> TSRT2-N’
<400> 16
acgacgtccg gggtctacta ggggggacga aggattacgt cctcagcg 48
<210> 17
<211> 25
<212> DNA
<213> artificial sequence
<220>
<223> TSF1
<400> 17
cttctccctc agtggccgcc tacta 25
<210> 18
<211> 15
<212> DNA
<213> artificial sequence
<220>
<223> TSF1-N’
<400> 18
gaagagggag tcacc 15
<210> 19
<211> 25
<212> DNA
<213> artificial sequence
<220>
<223> TSF2
<400> 19
agaactcttc cttctgcccc ccgag 25
<210> 20
<211> 15
<212> DNA
<213> artificial sequence
<220>
<223> TSF2-N’
<400> 20
tcttgagaag gaaga 15
<210> 21
<211> 270
<212> DNA
<213> artificial sequence
<220>
<223> NS
<400> 21
agatctcgat cctctacgcc ggacgcatcg tggccggcat caccggcgcc acaggtgcgg ttgctggcgc ctatatcgcc gacatcaccg atggggaaga tcgggctcgc cacttcgggc tcatgagcgc ttgtttcggc gtgggtatgg tggcaggccc cgtggccggg ggactgttgg gcgccatctc cttgcatgca ccattccttg cggcggcggt gctcaacggc ctcaacctac tactgggctg cttcctaatg caggagtcgc 270
<210> 22
<211> 370
<212> DNA
<213> artificial sequence
<220>
<223> NS1
<400> 22
agatctcgat cctctacgcc ggacgcatcg tggccggcat caccggcgcc acaggtgcgg ttgctggcgc ctatatcgcc gacatcaccg atggggaaga tcgcaaattg tcgcggcgat taaatctcgc gccgatcaac tgggtgccag cgtggtggtg tcgatggtag aacgaagcgg cgtcgaagcc tgtaaagcgg tcgggctcgc cacttcgggc tcatgagcgc ttgtttcggc gtgggtatgg tggcaggccc cgtggccggg ggactgttgg gcgccatctc cttgcatgca ccattccttg cggcggcggt gctcaacggc ctcaacctac tactgggctg cttcctaatg caggagtcgc 370
<210> 22
<211> 470
<212> DNA
<213> artificial sequence
<220>
<223> NS2
<400> 22
agatctcgat cctctacgcc ggacgcatcg tggccggcat caccggcgcc acaggtgcgg ttgctggcgc ctatatcgcc gacatcaccg atggggaaga tcgcaaattg tcgcggcgat taaatctcgc gccgatcaac tgggtgccag cgtggtggtg tcgatggtag aacgaagcgg cgtcgaagcc tgtaaagcgg ccgctggatg accaggatgc cattgctgtg gaagctgcct gcactaatgt tccggcgtta tttcttgatg tctctgacca gacacccatc aacagtatta tcgggctcgc cacttcgggc tcatgagcgc ttgtttcggc gtgggtatgg tggcaggccc cgtggccggg ggactgttgg gcgccatctc cttgcatgca ccattccttg cggcggcggt gctcaacggc ctcaacctac tactgggctg cttcctaatg caggagtcgc 470
Claims (9)
1. the length for multiplex ligation amplification technology relies on probe to preparation method, comprises the preparation of long probe and the preparation of short probe.
2. according to the length for multiplex ligation amplification technology described in claim 1, rely on probe to preparation method, it is characterized in that, the preparation method of described long probe comprises the following steps:
1) design the irrelevant universal primer of native sequences in target fragment a pair of and to be measured and long probe, GSF and GSR, for last PCR augmentation detection;
2) determine one section with long probe and the irrelevant native sequences NS of universal primer, and for designing the primer of pair for amplification long probe, be respectively GRS-N ' and GSF-N ', wherein GSR-N ' is comprised of the sequence of the sequence of GSR and the 18bp left and right of NS sequence 3 ' end, TSR-N ' is comprised of the sequence of the reverse complementary sequence of object long probe 5 ' terminal sequence and the 18bp left and right reverse complemental of NS sequence 5 ' end, and the 5 ' end of TSR-N ' will be with phosphorylation modification;
3) with GRS-N ' and GSF-N ' take described one section as template, carry out PCR amplification with probe and the irrelevant nucleotide sequence of universal primer, obtain the Double-stranded nucleotide sequence of complementary strand 5 ' end phosphorylation modification;
4) purifying reclaims PCR product;
5) adopt T7 exonuclease to digest above dsDNA sequence, remove that ssDNA of 5 ' phosphorylation mark;
6), according to the needs of test set, 3 ' end of long probe is carried out to the modification of reporter group;
7) adopt ssDNA purifying to reclaim test kit digestion product is reclaimed, just obtain long probe.
3. the length for multiplex ligation amplification technology according to claim 2 relies on the preparation method of probe to long probe, it is characterized in that, step 2) described native sequences NS, native sequences can be selected any and target gene fragment and the irrelevant sequence of universal primer.
4. the length for multiplex ligation amplification technology according to claim 2 relies on the preparation method of probe to long probe, it is characterized in that, and the modification of the reporter group described in step 6), reporter group can be used FAM, HAX, Cys5, Cys3.
5. according to the probe preparation method for multiplex ligation amplification technology described in claim 2, it is characterized in that, the Double-stranded nucleotide sequence of 5 ' the end phosphorylation modification that PCR amplification obtains described in step 3) need first carry out the digestion of T7 excision enzyme through purifying again.
6. the probe preparation method for multiplex ligation amplification technology according to claim 2, is characterized in that, in the T7 excision enzyme digestive process described in step 5), 1ugdsDNA digests with 1 T7 of unit excision enzyme.
7. according to the length for multiplex ligation amplification technology described in claim 1, rely on probe to preparation method, it is characterized in that, the preparation method of described short probe comprises the following steps:
1) for short probe, relate to pair for amplification primer, be respectively GSF-N ' and TSF-N ', wherein GSF-N ' is comprised of the sequence of the 18bp left and right of the sequence 5 ' end of GSF, the sequence of the 18bp left and right reverse complemental of TSF-N ' in the reverse complementary sequence of TSF sequence 3 ' end forms, and its 5 ' end will be with phosphorylation modification;
2) with GSF-N ' and TSF-N ', take the nucleotide sequence of described long probe and carry out pcr amplification as template, obtain the Double-stranded nucleotide sequence of complementary strand 5 ' end phosphorylation modification;
3) purifying reclaims PCR product;
4) Double-stranded nucleotide sequence of the PCR product after adopting T7 exonuclease to above purifying digests, and removes that ssDNA of 5 ' end phosphorylation mark;
5) adopt ssDNA purifying to reclaim test kit digestion after product is reclaimed, obtain the short probe that length relies on probe centering.
8. according to the probe preparation method for multiplex ligation amplification technology described in claim 7, it is characterized in that, the Double-stranded nucleotide sequence of 5 ' the end phosphorylation modification that PCR amplification obtains described in step 3) need first carry out the digestion of T7 excision enzyme through purifying again.
9. the probe preparation method for multiplex ligation amplification technology according to claim 7, is characterized in that, in the T7 excision enzyme digestive process described in step 5), 1ugdsDNA digests with 1 T7 of unit excision enzyme.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410363255.4A CN104099424A (en) | 2014-07-29 | 2014-07-29 | Method for preparing length relying probe for detecting gene mutation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410363255.4A CN104099424A (en) | 2014-07-29 | 2014-07-29 | Method for preparing length relying probe for detecting gene mutation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104099424A true CN104099424A (en) | 2014-10-15 |
Family
ID=51667962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410363255.4A Pending CN104099424A (en) | 2014-07-29 | 2014-07-29 | Method for preparing length relying probe for detecting gene mutation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104099424A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104694630A (en) * | 2015-02-02 | 2015-06-10 | 江苏佰龄全基因生物医学技术有限公司 | Preparation method of probe for multiplex ligation-dependent probe amplification |
CN105803055A (en) * | 2014-12-31 | 2016-07-27 | 天昊生物医药科技(苏州)有限公司 | New target gene regional enrichment method based on multiple circulation extension connection |
WO2019144582A1 (en) * | 2018-01-26 | 2019-08-01 | 厦门艾德生物医药科技股份有限公司 | Probe and method for high-throughput sequencing targeted capture target region used for detecting gene mutations as well as known and unknown gene fusion types |
-
2014
- 2014-07-29 CN CN201410363255.4A patent/CN104099424A/en active Pending
Non-Patent Citations (4)
Title |
---|
熊丽等: "多重连接依赖性探针扩增技术及其在临床中的应用", 《妇产与遗传(电子版)》 * |
熊丽等: "多重连接依赖性探针扩增技术及其在临床中的应用", 《妇产与遗传(电子版)》, vol. 2, no. 1, 31 March 2012 (2012-03-31) * |
胡晓等: "多重连接依赖性探针扩增技术及其应用进展", 《现代生物医学进展》 * |
胡晓等: "多重连接依赖性探针扩增技术及其应用进展", 《现代生物医学进展》, vol. 10, no. 02, 31 January 2010 (2010-01-31) * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105803055A (en) * | 2014-12-31 | 2016-07-27 | 天昊生物医药科技(苏州)有限公司 | New target gene regional enrichment method based on multiple circulation extension connection |
CN104694630A (en) * | 2015-02-02 | 2015-06-10 | 江苏佰龄全基因生物医学技术有限公司 | Preparation method of probe for multiplex ligation-dependent probe amplification |
CN104694630B (en) * | 2015-02-02 | 2017-05-24 | 江苏佰龄全基因生物医学技术有限公司 | Preparation method of probe for multiplex ligation-dependent probe amplification |
WO2019144582A1 (en) * | 2018-01-26 | 2019-08-01 | 厦门艾德生物医药科技股份有限公司 | Probe and method for high-throughput sequencing targeted capture target region used for detecting gene mutations as well as known and unknown gene fusion types |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101619352B (en) | Double-probe gene mutation detecting method based on allele special amplification as well as special chip and kit thereof | |
CN104946632A (en) | Autosome STR gene locus fluorescent labeling composite amplification kit having enhanced identification ability, and applications thereof | |
CN104372093A (en) | SNP (single-nucleotide polymorphism) detection method based on high-flux sequencing | |
CN107385024B (en) | Rice fertility restorer gene assisted breeding molecular marker and application thereof | |
CN108103164B (en) | Method for detecting copy number variation by using multiple fluorescent competitive PCR | |
CN109504753B (en) | Genetic deafness related gene detection chip kit | |
Zhou et al. | Simultaneous multiple single nucleotide polymorphism detection based on click chemistry combined with DNA-encoded probes | |
CN110358815B (en) | Method for simultaneously detecting multiple target nucleic acids and kit thereof | |
CN111996290A (en) | SARS-CoV-2 whole genome nucleic acid amplification specific primer based on multiple PCR | |
CN103898226B (en) | A kind of plastosome SNP fluorescence labeling composite amplification test kit and application thereof | |
CN104894233A (en) | Multi-sample and multi-segment DNA methylation high-throughput sequencing method | |
CN106755448A (en) | 29 fluorescence labeling composite amplification kits of str locus seat of human Y-chromosome | |
CN104450872A (en) | High-throughput multi-sample multi-target sing-base resolution methylation level detection method | |
CN104099424A (en) | Method for preparing length relying probe for detecting gene mutation | |
CN109295500B (en) | Single cell methylation sequencing technology and application thereof | |
CN108753933B (en) | Real-time fluorescent quantitative PCR detection method and kit based on metal ruthenium complex | |
CN102399900B (en) | Gene polymorphism detection method and kit | |
CN106319079B (en) | Method for detecting 22q11.2 copy number loss | |
CN107937493B (en) | Hairpin modified primer for allele PCR | |
CN109929936B (en) | Fluorescence labeling multiplex amplification kit for detecting human Y chromosome rapid mutation STR locus and application | |
CN111808994A (en) | RPA primer and detection method for detecting banana streak virus GF isolate | |
CN107988334B (en) | Method for SNP typing by direct PCR of oral swab | |
CN111560442A (en) | Compound amplification kit for paternity test and individual identification of cattle and application | |
WO2022246783A1 (en) | Probe composition for identifying or assisting identification of mammalian species, and kit and application thereof | |
CN102605088B (en) | Method for rapidly detecting copy number variation of alpha-globin gene cluster |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 200444, building 4, block E, 3100 Hu Tai Road, Shanghai, Yangpu District Applicant after: Shanghai Zhongyou Medicine High-tech Co., Ltd. Address before: 200433, room 11, 705-706 Cathay Pacific Road, Shanghai, Yangpu District Applicant before: Shanghai Zhongyou Medicine High-tech Co., Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200433 YANGPU, SHANGHAI TO: 200444 YANGPU, SHANGHAI |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141015 |